HT-102 not checked

Suzhou HepaThera Biotech Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
3 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“HT-101 given by subcutaneous injection.HT-102 given by subcutaneous injection.”In the company’s words, NCT07917910 on ClinicalTrials.gov
Tested for
Chronic Hepatitis B (2 trials), Chronic Hepatitis B Virus Infection
Main trialPhase 2
“This study is A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical study to evaluate the efficacy and safety of HT-101 injection combined with HT-102 injection in patients with chronic hepatitis B. It consists of two phases: the main trial and the extension period. The main trial phase aims to explore the efficacy of different courses of HT-101 injection combined with HT-102 injection in treating patients with chronic hepatitis B and evaluate the optimal treatment strategy. The extension period phase, based on the main trial, assesses the long-term safety and efficacy…”In the company’s words, NCT07245953 on ClinicalTrials.gov

Other drugs for Chronic Hepatitis B

All 33 drugs for Chronic Hepatitis B

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting Feb 2027 A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
Phase 2Not yet recruiting 30 Oct 2028 A Study of HT-101 and HT-102 in Chronic Hepatitis B (CHB)
Phase 1/2Active, not recruiting 24 Aug 2027 A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
Phase 1Completed 12 Mar 2024 Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients With Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow HT-102

Following is part of Solo: you see every change to HT-102 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in